Publication | Closed Access

Determination of daunorubicin and its main metabolites in plasma, urine and leukaemic cells in patients with acute myeloblastic leukaemia

Hematological MalignancyLeukaemic CellsBiochemistryMedicineMalignant Blood DisorderBioanalysisHematologyMyeloid NeoplasiaPathologyAcute Myeloblastic LeukaemiaMetabolomicsPharmacologyMain Metabolites